S&P 500 and Nasdaq Composite hit new highs overnight, propelled by robust economic data and upbeat corporate earnings.
Hong Kong virtual insurer Bowtie Life raises US$70 million in third funding round
Bowtie Life Insurance, the city’s first virtual insurer, on Friday said it raised US$70 million in its third funding round from existing shareholder Sun Life, its largest such effort since its ...
Hong Kong’s April-June unemployment holds steady at 3.5%
Hong Kong's seasonally adjusted unemployment rate held steady at 3.5% in April to June compared with the previous three-month period, with unemployment mainly in the construction, food and beverage ...
Hongkong Post suspends the postal service for items … – Fox Business
Hongkong Post said Wednesday they will not be collecting any "so-called tariffs on behalf of the US" and they are suspending service of postal items containing goods shipped to the US.
Hong Kong stocks rise as China steps in to curb EV sector competition
At a meeting chaired by Premier Li Qiang on Wednesday, authorities pledged to curb ‘irrational competition’ in the EV sector.
Hong Kong’s $32 billion pile of bad debt spurs talks to form ‘bad bank’
Hong Kong’s banks are coming under increasing pressure to offload loans backed by real estate assets. Read more at straitstimes.com. Read more at straitstimes.com.
MiniMax, the ‘world-class’ AI start-up lauded by Jensen Huang, applies for Hong Kong IPO
MiniMax aimed to raise between HK$4 billion and HK$5 billion, but its deal size and valuation could change depending on market conditions, Reuters said.
Ex-McKinsey Partner Sentenced in Obstruction Case
The consultant had deleted records involving McKinsey’s role in pushing OxyContin sales and driving the opioid crisis.
Consulting firm McKinsey to pay $650 million to resolve US opioid …
McKinsey & Co has agreed to pay $650 million to resolve charges over advice it provided Purdue Pharma on how to "turbocharge" sales of its addictive painkiller OxyContin, the U.S. Department of ...
McKinsey to pay $650 million for helping Purdue Pharma sell OxyContin
McKinsey & Company agreed to pay $650 million to resolve criminal and civil investigations into its advice to opioids manufacturer Purdue Pharma.
The scandals and hypocrisy behind McKinsey’s sterling reputation
The consulting giant's unsavory practices are hidden by a “culture of secrecy,” Walt Bogdanich and Michael Forsythe write.
Ex-McKinsey partner sentenced to 6 months in prison for obstructing …
A former senior partner at McKinsey & Company was sentenced on Friday to six months in federal prison for destroying records of the firm’s work to “turbocharge” Purdue Pharma’s OxyContin ...
Hong Kong’s asset management industry hits near-record US$4.5 trillion on massive inflows
The city continues to be a top cross-border wealth centre, with non-Hong Kong investors contributing 63 per cent of assets under management.
What is Hong Kong’s allure for China’s tourists? Financial service …
Hong Kong companies have reason to be optimistic about the return of Greater Bay Area’s (GBA) affluent tourists, but McKinsey & Company cautions that the city no longer is the no-brainer ...